drugset / Trial / NCT04238923

Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis

NCT04238923

RandomizedParallel-groupTriple-blindPrevention

Summary

Many patients who undergo vascular surgery to improve the blood flow to their legs are at risk of developing an infection in the surgical site and are then at risk of serious complications such as hospital readmission, failure of the surgical procedure and lower limb amputation. Surgical site infections may be reduced in high-risk patients by applying two commonly used antibiotics (gentamicin and vancomycin) into the surgical incision at the end of the surgical procedure. This will be compared to the standard of care treatment at London Health Sciences Center.

Timeline

Start
2020-05-01
Primary completion
2021-05-01
Completion
2021-07-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Gentamicin Small molecule 2 unknown Topical
Subject Vancomycin Other / unclassified 1 g Topical